GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

Type 1 diabetes was linked to increased risk for dementia, especially vascular dementia, non-Alzheimer-nonvascular dementia, and Alzheimer disease.

At the 61st European Association for the Study of Diabetes in Vienna, Austria, researchers highlighted emerging evidence linking both type 1 diabetes (T1D) and type 2 diabetes (T2D) with dementia and ...

Please provide your email address to receive an email when new articles are posted on . Patients with diabetes and CAD had a 37% higher risk for developing all-cause dementia than those with neither ...

There is a new warning about diabetes triggering another medical challenge. Type 2 diabetes is rampant in our country and growing in incidence. Now doctors warn an early diabetes diagnosis could ...

Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University A Korean study published recently suggests people with type 2 diabetes who are prescribed ...

Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are ...

The real-world study illustrates the interconnectedness of type 2 diabetes (T2D), mental health outcomes, and diabetes complications, with major depression emerging as a T2D complication. A population ...

Are artificial sweeteners harmful to health? Can consuming them on a regular basis affect our memory? Find out key details ...

In a recent cohort study published in JAMA Network Open, researchers from China investigated the effect of a multidisciplinary diabetes management program on the risk of dementia in patients with type ...

People with dementia who received a shingles vaccine were significantly less likely to die from dementia than those who ...